Norges Bank’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-112,500
Closed -$5.21M – 1647
2025
Q4
$5.21M Buy
+112,500
New +$4.71M ﹤0.01% 1382
2017
Q1
– Sell
-30,000
Closed -$467K – 2147
2016
Q4
$467K Buy
+30,000
New +$499K ﹤0.01% 2118
2015
Q3
– Sell
-20,000
Closed -$357K – 2291
2015
Q2
$357K Buy
+20,000
New +$346K ﹤0.01% 2205

Other funds holding COLL

Norges Bank's COLL Position: Q2 2026 in Review

Norges Bank sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 112,500 shares — an estimated $5.21M sold.

Norges Bank first reported a position in COLL in Q2 2015 and held it in 3 quarters. The position peaked at $5.21M in Q4 2025. 281 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Norges Bank reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Norges Bank sold 112,500 Collegium Pharmaceutical shares in Q2 2026, an estimated $5.21M.
  • Norges Bank first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 3 quarters.
  • Norges Bank's Collegium Pharmaceutical position peaked at $5.21M in Q4 2025.
  • 281 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.